ASP Isotopes Inc. (ASPI)

Market Cap	337.68M
Revenue (ttm)	3.38M
Net Income (ttm)	-30.09M
Shares Out	71.39M
EPS (ttm)	-0.61
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,389,774
Open	4.300
Previous Close	4.190
Day's Range	4.220 - 4.810
52-Week Range	1.860 - 9.330
Beta	3.69
Analysts	Strong Buy
Price Target	4.50 (-4.86%)
Earnings Date	May 14, 2025

About ASPI

ASP Isotopes Inc., a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc. was incorporated in 2021 and is headquartered in Washington, District Of Columbia.

• Industry: Chemicals
• Sector: Materials
• IPO Date: Nov 10, 2022
• Employees: 76
• Stock Exchange: NASDAQ
• Ticker Symbol: ASPI
• Website: https://aspisotopes.com

Analyst Forecast

According to 2 analysts, the average rating for ASPI stock is "Strong Buy." The 12-month stock price forecast is $4.5, which is a decrease of -4.86% from the latest price.

Price Target

$4.5

(-4.86% downside)

Analyst Consensus: Strong Buy